alternative to tirzepatide Standard Plan: Generic – Get Tested South Africa FDA Approves New Weight Loss

A drug that has been previously approved, even for a different indication in a different patient population, does not qualify

Read the guide Weight Loss in 2026: Understanding Your Medical and Lifestyle Options Weight management is the #1 reason Texans seek virtual care

Proper patient selection, baseline blood work, and ongoing clinical monitoring are essential to ensure the therapy is safe, effective, and correctly tailored to the patients specific metabolic needs

Fixing these small habits often brings back balance without needing to change doses

REDEFINE 1 was a 68-week, double-blind, placebo- and active-controlled efficacy and safety phase 3 trial of once-weekly CagriSema, cagrilintide 2.4 mg and semaglutide 2.4 mg versus placebo in 3,417 adults with obesity or overweight with one or more comorbidities and without type 2 diabetes